1Berger J,Hingais N.Zntercap illary depsits of IgA -IgG[J].J U-rol Nephrol (pan's),1968,74(9):694-695.
2Berthoux FC,Mohey H,A fiani A.Natural history of p rimary IgA nephropathy[J].Sem in Neph rol,2008,28(1):4-9.
3Samuels JA,Strippoli GF,Craig JC,et al.Immunosupp ressive treatments for immunoglobulin A nephropathy:A meta-analysis of randomized controlled trials[J].N ephrology(Carlton),2004,9(4):177-185.
4Pozzi C,Andrulli S,del Vecchio L,et al.Corticosteroid effectiveness in IgA nephropathy:Long-term results of a randomized,controlled trial[J].J Am Soc N ephrol,2004,15(1):157- 163.
8Li PK,Leung CB,Chow KM,et al.Hong Kong study using valsartan in IgA nephropathy (HKV IN):A double-blind,randomized,placebo -controlled study[J].Am J Kidney Dis,2006,47(5):751- 760.
10Ballardie FW,Roberts IS.Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy[J].J Am Soc Nephrol,2002,13 (1):142-148.
7Sano T, Hiki Y, Kokubo T, et al. Enzymatically deglycosylated human lgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli[ J]. Nephrol Dial Transplant ,2002,17 ( 1 ) :50 - 56.
8Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy[ J]. Serain Nephrol,2004,24 ( 3 ) : 197 - 217.
9Levy M, Gonzalez- Burchard G,Broyer M,et al. Berger's, disease in children. Natural history and outcome [ J ]. Medicine ( Baltimore), 1985, 64(3) :157 - 180.
10Yoshikawa N,Ito H,Sakai T,et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy[ J]. J Am Soc Nephrol.1999,10( 1 ) :101 - 109.
